Subscribe

Bangkok Dusit Medical Services Public Company Limited (BDMS-R.BK)

THB19.30 -0.10 (-0.52%)
TH SET Healthcare Medical - Care Facilities
Address 2, Soi Soonvijai 7 10310
Bangkok, TH
CEO Poramaporn Prasarttong-Osoth
Website bdms.co.th
IPO 2007-12-28
ISIN TH0264010R10

Explore sections of this company profile

Also trades on Other OTC · BDULF (USD) Other OTC · BDUUF (USD) Other OTC · BDUUY (USD) Stock Exchange of Thailand · BDMS-R.BK (THB) Stock Exchange of Thailand · BDMS.BK (THB)
Description

Bangkok Dusit Medical Services Public Company Limited, along with its affiliated entities, primarily operates and manages hospitals. The company oversees six distinct hospital networks: the Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. In addition to core healthcare services, it offers comprehensive clinical wellness programs. Its business activities also span numerous other sectors, including hotel and restaurant operations, and the sale of health and cosmetic items. BDMS provides a diverse range of services, such as accounting, health insurance, laboratory testing, investment management, information technology, professional training, specialized skin and aesthetics telemedicine, genome sequencing, insurance brokerage, and air medical transportation. The company also handles facility, property, and asset management. Furthermore, it is involved in the production and distribution of medicines and pharmaceutical products. Its portfolio also extends to e-commerce and real estate ventures. The company maintains a substantial footprint, operating 47 hospitals across Thailand and Cambodia. Established in 1969, Bangkok Dusit Medical Services Public Company Limited is based in Bangkok, Thailand.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
THB19.30 -0.10 (-0.52%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
65M
Beta
0.28
Float Shares
11.40B
Free Float %
71.7%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-1.08% -0.54% -2.14% -16.06% -5.18% -10.73% -20.43% -37.44% -12.44% -22.13% +454.55%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
19.30
DCF (Unlevered) 24.43 +26.6%
DCF (Levered) 27.74 +43.7%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Quality scores
Altman Z-Score
5.39
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Medical - Care Facilities: +10.2%
    +3.4% Q1'26: +0.3% (vs Q1'25)
  • ✗
    EPS growth Medical - Care Facilities: +19.2%
    -1.0% Q1'26: -3.7% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +12.1% Q1'26: +17.1% (vs Q1'25)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    +16.6% ★ Q1'26: +17.2% (vs Q1'25)
  • ✗
    ROIC Medical - Care Facilities: +6.8%
    +11.8% ★ Q1'26: +13.0% (vs Q1'25)
  • ✓
    Share dilution Medical - Care Facilities: +0.0%
    +0.0% Q1'26: +0.0% (vs Q1'25)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    0.99× ★ Q1'26: 0.53× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.30) × ERP
WACC = 92% × Ke + 8% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 24.06 Current price: 19.30
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
3 Rev. Ana.
1 EPS Ana. 		Dec 2027
13 Rev. Ana.
1 EPS Ana. 		Dec 2028
8 Rev. Ana.
1 EPS Ana.
Revenue
62.86B
est: 61.60B (+2.0%)
67.99B
est: 67.47B (+0.8%)
71.93B
est: 70.51B (+2.0%)
78.42B
est: 78.02B (+0.5%)
82.72B
est: 82.23B (+0.6%)
68.07B
est: 67.93B (+0.2%)
74.45B
est: 72.68B (+2.4%)
91.93B
est: 90.41B (+1.7%)
100.85B
est: 99.53B (+1.3%)
107.87B
est: 108.34B (-0.4%)
111.51B
est: 111.45B (+0.1%)
114.54B
114.38B – 114.79B
+2.8% YoY
120.21B
117.67B – 125.14B
+4.9% YoY
125.72B
124.27B – 128.50B
+4.6% YoY
EBITDA
14.22B
est: 15.27B (-6.9%)
15.01B
est: 16.73B (-10.3%)
18.42B
est: 17.48B (+5.4%)
17.21B
est: 19.34B (-11.0%)
25.49B
est: 20.39B (+25.0%)
17.41B
est: 16.84B (+3.4%)
17.62B
est: 18.02B (-2.2%)
23.02B
est: 22.42B (+2.7%)
24.96B
est: 24.68B (+1.1%)
26.90B
est: 26.24B (+2.5%)
25.31B
est: 26.99B (-6.2%)
27.74B
27.70B – 27.80B
+2.8% YoY
29.11B
28.50B – 30.31B
+4.9% YoY
30.45B
30.10B – 31.12B
+4.6% YoY
EBIT
11.37B
est: 10.85B (+4.7%)
10.21B
est: 11.89B (-14.2%)
13.26B
est: 12.42B (+6.7%)
11.87B
est: 13.75B (-13.7%)
19.79B
est: 14.49B (+36.6%)
11.00B
est: 11.97B (-8.1%)
11.30B
est: 12.81B (-11.8%)
17.07B
est: 15.93B (+7.2%)
19.11B
est: 17.54B (+9.0%)
20.76B
est: 19.78B (+5.0%)
18.46B
est: 20.35B (-9.3%)
20.91B
20.88B – 20.96B
+2.8% YoY
21.95B
21.48B – 22.85B
+4.9% YoY
22.95B
22.69B – 23.46B
+4.6% YoY
Net Income
7.92B
est: 7.83B (+1.1%)
8.39B
est: 8.71B (-3.7%)
10.22B
est: 9.44B (+8.2%)
9.19B
est: 10.25B (-10.4%)
15.52B
est: 15.67B (-1.0%)
7.21B
est: 6.61B (+9.1%)
7.94B
est: 7.45B (+6.5%)
12.61B
est: 12.21B (+3.2%)
14.38B
est: 13.89B (+3.5%)
15.99B
est: 15.64B (+2.2%)
15.85B
est: 16.21B (-2.2%)
16.46B
16.21B – 16.93B
+1.5% YoY
17.38B
17.12B – 17.88B
+5.6% YoY
18.31B
18.03B – 18.83B
+5.3% YoY
SGA
12.83B
est: 12.21B (+5.0%)
13.64B
est: 13.38B (+2.0%)
14.49B
est: 13.98B (+3.6%)
16.00B
est: 15.47B (+3.4%)
17.45B
est: 16.31B (+7.0%)
14.16B
est: 13.47B (+5.1%)
15.03B
est: 14.41B (+4.3%)
17.65B
est: 17.93B (-1.5%)
19.81B
est: 19.74B (+0.4%)
20.83B
est: 20.95B (-0.6%)
20.46B
est: 21.55B (-5.1%)
22.15B
22.12B – 22.20B
+2.8% YoY
23.24B
22.75B – 24.20B
+4.9% YoY
24.31B
24.03B – 24.85B
+4.6% YoY
EPS
0.52
est: 0.49 (+5.5%)
0.54
est: 0.55 (-1.5%)
0.66
est: 0.59 (+11.1%)
0.59
est: 0.65 (-8.6%)
0.99
est: 0.99 (+0.4%)
0.45
est: 0.42 (+8.2%)
0.50
est: 0.47 (+6.6%)
0.79
est: 0.77 (+2.8%)
0.90
est: 0.87 (+3.0%)
1.01
est: 0.98 (+2.6%)
1.00
est: 1.02 (-1.9%)
1.04
1.02 – 1.07
+1.5% YoY
1.09
1.08 – 1.13
+5.6% YoY
1.15
1.13 – 1.19
+5.3% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-13 B+ 3/5 4/5 4/5 5/5 2/5 2/5 2/5
2026-05-12 B+ 3/5 4/5 4/5 5/5 2/5 2/5 2/5
2026-05-11 A- 4/5 4/5 4/5 5/5 2/5 3/5 2/5
2026-05-08 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-05-07 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-05-06 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-05-05 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-30 A- 4/5 4/5 4/5 5/5 2/5 3/5 2/5
2026-04-29 A- 4/5 4/5 4/5 5/5 2/5 3/5 2/5
2026-04-28 A- 4/5 4/5 4/5 5/5 2/5 3/5 2/5
2026-04-27 A- 4/5 4/5 4/5 5/5 2/5 3/5 2/5
2026-04-24 A- 4/5 4/5 4/5 5/5 2/5 3/5 2/5
2026-04-23 B+ 3/5 4/5 4/5 5/5 1/5 3/5 2/5
2026-04-22 B+ 3/5 4/5 4/5 5/5 1/5 3/5 2/5
2026-04-21 A- 4/5 4/5 4/5 5/5 1/5 3/5 3/5
2026-04-20 A- 4/5 4/5 4/5 5/5 1/5 3/5 3/5
2026-04-17 A- 4/5 4/5 4/5 5/5 1/5 3/5 3/5
2026-04-16 A- 4/5 4/5 4/5 5/5 1/5 3/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
16.05B
OE per share TTM
1.01
Owner's Yield
5.55%
Maintenance CapEx ratio
31.76%
Maint CapEx / Avg PPE
102.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
458.2K
Shares Outstanding
15.89B

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Poramaporn Prasarttong-Osoth President, Senior Chief Executive Officer of Group 1 & Authorized Director 8M female
Narumol Noi-Am Senior EVice President, Chief Financial Officer & Authorized Director 8M female
Chuladej Yossundharakul Executive Vice Chairman 8M male
Chairat Panthuraamphorn Chief Operating Officer & Executive Director 8M male
Pradit Theekakul Authorized Director 7M male
Sripop Sarasas Chief Administration Officer & Authorized Director 7M male
Att Thongtang Executive Director & Chief Executive Officer of Group 5 7M male
Daranee Bunchongsilp Head of Internal Audit — female
Chokchai Jarusiripipat Chief Medical Officer — male
Ajaya Intaraprasong Head of the Investor Relations — female
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities